Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1996 Dec 7;313(7070):1419–1420. doi: 10.1136/bmj.313.7070.1419

Heart attacks and homocysteine.

I Graham, R Meleady
PMCID: PMC2353008  PMID: 8973221

Full text

PDF
1419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M., Smith P. D., Martin D., Thompson J. R., Lodwick D., Samani N. J. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. QJM. 1996 Jun;89(6):437–444. doi: 10.1093/qjmed/89.6.437. [DOI] [PubMed] [Google Scholar]
  2. Arnesen E., Refsum H., Bønaa K. H., Ueland P. M., Førde O. H., Nordrehaug J. E. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995 Aug;24(4):704–709. doi: 10.1093/ije/24.4.704. [DOI] [PubMed] [Google Scholar]
  3. Boushey C. J., Beresford S. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4;274(13):1049–1057. doi: 10.1001/jama.1995.03530130055028. [DOI] [PubMed] [Google Scholar]
  4. Daly L., Robinson K., Tan K. S., Graham I. M. Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences? Q J Med. 1993 Oct;86(10):685–689. doi: 10.1093/qjmed/86.10.685. [DOI] [PubMed] [Google Scholar]
  5. Engbersen A. M., Franken D. G., Boers G. H., Stevens E. M., Trijbels F. J., Blom H. J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995 Jan;56(1):142–150. [PMC free article] [PubMed] [Google Scholar]
  6. Jacques P. F., Bostom A. G., Williams R. R., Ellison R. C., Eckfeldt J. H., Rosenberg I. H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996 Jan 1;93(1):7–9. doi: 10.1161/01.cir.93.1.7. [DOI] [PubMed] [Google Scholar]
  7. Joosten E., van den Berg A., Riezler R., Naurath H. J., Lindenbaum J., Stabler S. P., Allen R. H. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr. 1993 Oct;58(4):468–476. doi: 10.1093/ajcn/58.4.468. [DOI] [PubMed] [Google Scholar]
  8. Kang S. S., Zhou J., Wong P. W., Kowalisyn J., Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet. 1988 Oct;43(4):414–421. [PMC free article] [PubMed] [Google Scholar]
  9. McCully K. S., Wilson R. B. Homocysteine theory of arteriosclerosis. Atherosclerosis. 1975 Sep-Oct;22(2):215–227. doi: 10.1016/0021-9150(75)90004-0. [DOI] [PubMed] [Google Scholar]
  10. Perry I. J., Refsum H., Morris R. W., Ebrahim S. B., Ueland P. M., Shaper A. G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995 Nov 25;346(8987):1395–1398. doi: 10.1016/s0140-6736(95)92407-8. [DOI] [PubMed] [Google Scholar]
  11. Robinson K., Mayer E. L., Miller D. P., Green R., van Lente F., Gupta A., Kottke-Marchant K., Savon S. R., Selhub J., Nissen S. E. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation. 1995 Nov 15;92(10):2825–2830. doi: 10.1161/01.cir.92.10.2825. [DOI] [PubMed] [Google Scholar]
  12. Selhub J., Jacques P. F., Wilson P. W., Rush D., Rosenberg I. H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993 Dec 8;270(22):2693–2698. doi: 10.1001/jama.1993.03510220049033. [DOI] [PubMed] [Google Scholar]
  13. Stampfer M. J., Malinow M. R., Willett W. C., Newcomer L. M., Upson B., Ullmann D., Tishler P. V., Hennekens C. H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992 Aug 19;268(7):877–881. [PubMed] [Google Scholar]
  14. Wilcken D. E., Wang X. L., Sim A. S., McCredie R. M. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol. 1996 Jul;16(7):878–882. doi: 10.1161/01.atv.16.7.878. [DOI] [PubMed] [Google Scholar]
  15. Wu L. L., Wu J., Hunt S. C., James B. C., Vincent G. M., Williams R. R., Hopkins P. N. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994 Apr;40(4):552–561. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES